Jun 23, 2026 04:40AM
Jun 22, 2026 08:00AM
Jun 22, 2026 08:00AM
May 6, 2026 08:00AM
Apr 27, 2026 05:21PM
Apr 27, 2026 05:21PM
Apr 6, 2026 06:41AM Taysha Gene Therapies (TSHA) PT Raised to $17 at Canaccord
Mar 25, 2026 07:22AM
Mar 19, 2026 01:54PM
Mar 19, 2026 08:00AM
Jan 6, 2026 10:31AM
Jan 6, 2026 08:02AM
Jan 6, 2026 08:00AM
Dec 4, 2025 05:08AM Goldman Sachs Upgrades Taysha Gene Therapies (TSHA) to Buy
Nov 5, 2025 05:11AM
Nov 4, 2025 07:00AM
Oct 20, 2025 04:10PM
Oct 16, 2025 04:02PM
Oct 16, 2025 04:01PM
Oct 9, 2025 08:00AM
Oct 9, 2025 08:00AM Taysha Gene Therapies Presents New Supplemental Data Analysis from Part A of the REVEAL Phase 1/2 Trials for TSHA-102 in Rett Syndrome at the 54th CNS Annual Meeting
Oct 2, 2025 01:04PM
Oct 2, 2025 08:00AM
Oct 2, 2025 08:00AM
Sep 12, 2025 04:11AM
Aug 12, 2025 08:01AM
Jul 11, 2025 06:37AM
Jun 3, 2025 05:26PM Taysha Gene Therapies (TSHA) announces presentations for TSHA-102 program
Jun 3, 2025 05:17PM
May 29, 2025 04:12AM
May 28, 2025 04:01PM
May 28, 2025 04:01PM
May 15, 2025 03:33PM
May 15, 2025 08:00AM
Feb 26, 2025 08:00AM Taysha Gene Therapies Reports Full-Year 2024 Financial Results and Provides Corporate Update
Jan 6, 2025 02:00PM
Nov 15, 2024 07:07AM
Nov 13, 2024 04:01PM
Oct 22, 2024 08:00AM
Sep 26, 2024 08:00AM
Aug 12, 2024 08:01AM
Jun 18, 2024 07:30AM Taysha Gene Therapies (TSHA) Announces Positive Clinical Data Across Adult and Pediatric Patients from Low Dose Cohort in REVEAL Phase 1/2 Trials
Jun 18, 2024 07:30AM
May 14, 2024 04:01PM
May 14, 2024 03:10AM
May 2, 2024 08:00AM
Mar 19, 2024 04:01PM
Feb 29, 2024 08:02AM
Feb 29, 2024 08:00AM Taysha Gene Therapies Announces Updates to TSHA-102 Clinical Program in Rett Syndrome
Jan 22, 2024 08:00AM

324,023 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All